Real-time enrollment status for this primary myelofibrosis clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:39 AM UTC
| NCT Number | NCT06517875 |
| Recruiting Status | Recruiting |
| Condition | Primary Myelofibrosis |
| Phase | Clinical Trial |
| Target Enrollment | 68 participants |
| Active Locations | 5 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | April 20, 2026 (Apr 20, 2026) |
As of July 13, 2026: Clinical trial NCT06517875 is currently recruiting participants. This clinical trial study for primary myelofibrosis is actively seeking new participants at 5 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06517875 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06517875 was last updated Apr 20, 2026 (April 20, 2026). HelloStudys verifies this status automatically.